Adam L. Stein is the founder and CEO of Advantageous Systems (ADS), a material science company integrating nanotechnology, chemistry, and biotechnology to produce smart materials with unique functional characteristics. Applications of ADS technology include medical and clean technology products. Stein was formerly with the U.S. Food and Drug Administration (FDA), where he conducted review and policy work. He is a co-inventor of the patented ADS minimally invasive analytes detection platform that uses conjugated nanoparticles to remove analytes selectively from the body without breaching skin. He is also the inventor of the patented ADS water remediation technology using functionalized particles and has extensive expertise in marketing novel technologies. He is an early stage investor in high tech and biotech companies and he regularly consults for companies and institutional financing groups regarding novel technologies and investment opportunities. He has served as a committee member and advisor to the US Environmental Protection Agency (EPA) SBIR program and the National Institutes of Health (NIH) Cancer Biomarkers Collaborative. Stein has a graduate biotechnology business degree and has extensive knowledge in both business and research related to the high-tech, biotech, and nanotechnology sectors.
Breakthrough: The Next Wave of Marketing